Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Chr Hansen
Chr Hansen
Activities:
Ingredients
Research & Development
Active Nutrition
Food
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Sustainability
Novozymes and Chr. Hansen join forces to create Novonesis
The two legacy companies collaborate to offer biosolutions to over 30 different industries
Chr Hansen and Lonza appoint new CEO for BacThera
Chr Hansen and Lonza joint venture company focuses on live-biotherapeutics has appointed Lukas Schüpbach as CEO
Ingredients
Chr. Hansen and Lonza joint venture: Ready for contract manufacturing
Companies have received the relevant approvals from anti-trust regulators for the 50/50 live biotherapeutic joint venture, BacThera
Manufacturing
Lonza and Chr. Hansen joint venture taps into microbiome boom
Companies engage in a three-year plan to provide a full supply chain offering for production of bacteria strains for therapeutic use
Design & Build
AF wins €5.5 million contract to modernise Chr Hansen plant
Will install a complete fermentation line for the production of probiotics at plant in Denmark
Subscribe now